222 related articles for article (PubMed ID: 35929764)
1. Characterization of TR-107, a novel chemical activator of the human mitochondrial protease ClpP.
Fennell EMJ; Aponte-Collazo LJ; Wynn JD; Drizyte-Miller K; Leung E; Greer YE; Graves PR; Iwanowicz AA; Ashamalla H; Holmuhamedov E; Lang H; Karanewsky DS; Der CJ; Houry WA; Lipkowitz S; Iwanowicz EJ; Graves LM
Pharmacol Res Perspect; 2022 Aug; 10(4):e00993. PubMed ID: 35929764
[TBL] [Abstract][Full Text] [Related]
2. Multi-omics analyses reveal ClpP activators disrupt essential mitochondrial pathways in triple-negative breast cancer.
Fennell EMJ; Aponte-Collazo LJ; Pathmasiri W; Rushing BR; Barker NK; Partridge MC; Li YY; White CA; Greer YE; Herring LE; Lipkowitz S; Sumner SCJ; Iwanowicz EJ; Graves LM
Front Pharmacol; 2023; 14():1136317. PubMed ID: 37063293
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial Protease ClpP is a Target for the Anticancer Compounds ONC201 and Related Analogues.
Graves PR; Aponte-Collazo LJ; Fennell EMJ; Graves AC; Hale AE; Dicheva N; Herring LE; Gilbert TSK; East MP; McDonald IM; Lockett MR; Ashamalla H; Moorman NJ; Karanewsky DS; Iwanowicz EJ; Holmuhamedov E; Graves LM
ACS Chem Biol; 2019 May; 14(5):1020-1029. PubMed ID: 31021596
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis.
Greer YE; Hernandez L; Fennell EMJ; Kundu M; Voeller D; Chari R; Gilbert SF; Gilbert TSK; Ratnayake S; Tang B; Hafner M; Chen Q; Meerzaman D; Iwanowicz E; Annunziata CM; Graves LM; Lipkowitz S
Cancer Res Commun; 2022 Oct; 2(10):1144-1161. PubMed ID: 36388465
[TBL] [Abstract][Full Text] [Related]
5. IMP075 targeting ClpP for colon cancer therapy in vivo and in vitro.
Zhang J; Luo B; Sui J; Qiu Z; Huang J; Yang T; Luo Y
Biochem Pharmacol; 2022 Oct; 204():115232. PubMed ID: 36030831
[TBL] [Abstract][Full Text] [Related]
6. ONC212 is a Novel Mitocan Acting Synergistically with Glycolysis Inhibition in Pancreatic Cancer.
Ferrarini I; Louie A; Zhou L; El-Deiry WS
Mol Cancer Ther; 2021 Sep; 20(9):1572-1583. PubMed ID: 34224362
[TBL] [Abstract][Full Text] [Related]
7. CLPP deficiency ameliorates neurodegeneration caused by impaired mitochondrial protein synthesis.
Rumyantseva A; Popovic M; Trifunovic A
Brain; 2022 Mar; 145(1):92-104. PubMed ID: 35240691
[TBL] [Abstract][Full Text] [Related]
8. Potent ClpP agonists with anticancer properties bind with improved structural complementarity and alter the mitochondrial N-terminome.
Mabanglo MF; Wong KS; Barghash MM; Leung E; Chuang SHW; Ardalan A; Majaesic EM; Wong CJ; Zhang S; Lang H; Karanewsky DS; Iwanowicz AA; Graves LM; Iwanowicz EJ; Gingras AC; Houry WA
Structure; 2023 Feb; 31(2):185-200.e10. PubMed ID: 36586405
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial Caseinolytic Protease P: A Possible Novel Prognostic Marker and Therapeutic Target in Cancer.
Cormio A; Sanguedolce F; Pesce V; Musicco C
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207660
[TBL] [Abstract][Full Text] [Related]
10. Imipridone Anticancer Compounds Ectopically Activate the ClpP Protease and Represent a New Scaffold for Antibiotic Development.
Jacques S; van der Sloot AM; C Huard C; Coulombe-Huntington J; Tsao S; Tollis S; Bertomeu T; Culp EJ; Pallant D; Cook MA; Bonneil E; Thibault P; Wright GD; Tyers M
Genetics; 2020 Apr; 214(4):1103-1120. PubMed ID: 32094149
[TBL] [Abstract][Full Text] [Related]
11. Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma.
Nguyen TTT; Shang E; Schiffgens S; Torrini C; Shu C; Akman HO; Prabhu VV; Allen JE; Westhoff MA; Karpel-Massler G; Siegelin MD
Clin Cancer Res; 2022 May; 28(9):1881-1895. PubMed ID: 35417530
[TBL] [Abstract][Full Text] [Related]
12. Substrates and interactors of the ClpP protease in the mitochondria.
Mabanglo MF; Bhandari V; Houry WA
Curr Opin Chem Biol; 2022 Feb; 66():102078. PubMed ID: 34446368
[TBL] [Abstract][Full Text] [Related]
13. Aberrant human ClpP activation disturbs mitochondrial proteome homeostasis to suppress pancreatic ductal adenocarcinoma.
Wang P; Zhang T; Wang X; Xiao H; Li H; Zhou LL; Yang T; Wei B; Zhu Z; Zhou L; Yang S; Lu X; Zhang Y; Huang Y; Gan J; Yang CG
Cell Chem Biol; 2022 Sep; 29(9):1396-1408.e8. PubMed ID: 35905743
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the structure-activity relationship and antileukemic activity of diacylpyramide compounds as human ClpP agonists.
Zhang R; Wang P; Wei B; Chen L; Song X; Pan Y; Li J; Gan J; Zhang T; Yang CG
Eur J Med Chem; 2023 Oct; 258():115577. PubMed ID: 37352796
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality.
Ishizawa J; Zarabi SF; Davis RE; Halgas O; Nii T; Jitkova Y; Zhao R; St-Germain J; Heese LE; Egan G; Ruvolo VR; Barghout SH; Nishida Y; Hurren R; Ma W; Gronda M; Link T; Wong K; Mabanglo M; Kojima K; Borthakur G; MacLean N; Ma MCJ; Leber AB; Minden MD; Houry W; Kantarjian H; Stogniew M; Raught B; Pai EF; Schimmer AD; Andreeff M
Cancer Cell; 2019 May; 35(5):721-737.e9. PubMed ID: 31056398
[TBL] [Abstract][Full Text] [Related]
16. Modulation of Mitochondrial ERβ Expression Inhibits Triple-Negative Breast Cancer Tumor Progression by Activating Mitochondrial Function.
Song IS; Jeong YJ; Jeong SH; Kim JE; Han J; Kim TH; Jang SW
Cell Physiol Biochem; 2019; 52(3):468-485. PubMed ID: 30873822
[TBL] [Abstract][Full Text] [Related]
17. Loss of conserved mitochondrial CLPP and its functions lead to different phenotypes in plants and other organisms.
Huang S; Petereit J; Millar AH
Plant Signal Behav; 2020 Dec; 15(12):1831789. PubMed ID: 33073672
[TBL] [Abstract][Full Text] [Related]
18. ONC201 and imipridones: Anti-cancer compounds with clinical efficacy.
Prabhu VV; Morrow S; Rahman Kawakibi A; Zhou L; Ralff M; Ray J; Jhaveri A; Ferrarini I; Lee Y; Parker C; Zhang Y; Borsuk R; Chang WI; Honeyman JN; Tavora F; Carneiro B; Raufi A; Huntington K; Carlsen L; Louie A; Safran H; Seyhan AA; Tarapore RS; Schalop L; Stogniew M; Allen JE; Oster W; El-Deiry WS
Neoplasia; 2020 Dec; 22(12):725-744. PubMed ID: 33142238
[TBL] [Abstract][Full Text] [Related]
19. ClpP/ClpX deficiency impairs mitochondrial functions and mTORC1 signaling during spermatogenesis.
Guo C; Xiao Y; Gu J; Zhao P; Hu Z; Zheng J; Hua R; Hai Z; Su J; Zhang JV; Yeung WSB; Wang T
Commun Biol; 2023 Oct; 6(1):1012. PubMed ID: 37798322
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of the mitochondrial matrix peptidase ClpP in muscle cells causes mitochondrial dysfunction and decreases cell proliferation.
Deepa SS; Bhaskaran S; Ranjit R; Qaisar R; Nair BC; Liu Y; Walsh ME; Fok WC; Van Remmen H
Free Radic Biol Med; 2016 Feb; 91():281-92. PubMed ID: 26721594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
